A general assay platform to study protein pharmacology using ligand-dependent structural dynamics

Area of Science:

• Chemical Biology
• Biophysics

Background:

• Drug design requires advanced high-throughput assays.
• Understanding protein dynamics is crucial for drug discovery.

Purpose of the Study:

• To develop a novel, general, and sensitive assay for ligand binding detection.
• To enable the study of proteins previously inaccessible due to assay limitations.

Main Methods:

• Fusing NanoLuc luciferase (or its peptide) to target proteins.
• Measuring ligand-induced changes in bioluminescence as a readout for binding.
• Applying the assay to chemical library screening.

Main Results:

• Demonstrated sensitive, ligand-dependent bioluminescent outputs from fused proteins.
• Established a quantitative, isothermal, gain-of-signal readout independent of protein function.
• Observed complex pharmacologic outputs, including synergistic and allosteric binding.

Conclusions:

• The structural dynamics response assay is a versatile tool for drug discovery.
• This assay format expands the scope of druggable targets and facilitates protein research.